Tag: Biopharmaceutical company
FDA Pauses Study on Amgen’s Obesity Treatment
The Food and Drug Administration (FDA) recently put a hold on Amgen's study of their early-stage obesity treatment, known as AMG 513, marking a...
BREAKING NEWS
Reevaluating the Failed ‘Skin in the Game’ Approach to Health Care...
Reevaluating the Failed 'Skin in the Game' Approach to Health Care SpendingIn a world where online vitriol often overshadows rational discourse, the recent attention-grabbing...
